Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors.

Helgebostad, Rasmus; Revheim, Mona-Elisabeth; Johnsrud, Kjersti; Amlie, Kristine; Alavi, Abass; Connelly, James Patrick

Helgebostad, Rasmus; Revheim, Mona-Elisabeth; Johnsrud, Kjersti; Amlie, Kristine; Alavi, Abass; Connelly, James Patrick.

Afiliação

Helgebostad R; Division of Radiology and Nuclear Medicine, Oslo University Hospital, P.O. Box 4956 Nydalen, 0424 Oslo, Norway.
Revheim ME; Division of Radiology and Nuclear Medicine, Oslo University Hospital, P.O. Box 4956 Nydalen, 0424 Oslo, Norway.
Johnsrud K; Institute of Clinical Medicine, University of Oslo, P.O. Box 1171 Blindern, 0318 Oslo, Norway.
Amlie K; Division of Radiology and Nuclear Medicine, Oslo University Hospital, P.O. Box 4956 Nydalen, 0424 Oslo, Norway.
Alavi A; Division of Radiology and Nuclear Medicine, Oslo University Hospital, P.O. Box 4956 Nydalen, 0424 Oslo, Norway.
Connelly JP; Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA.

Diagnostics (Basel) ; 12(2)2022 Feb 18.

Article em En | MEDLINE | ID: mdl-35204618

Palavras-chave

PET; atherosclerosis; benign; imaging; inflammation; malignant; osteomalacia; review; sarcoidosis; somatostatin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Qualitative_research / Systematic_reviews Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google